Mechanisms That Control Antigen Receptor Variable Region Exon Assembly
Mechanisms That Control Antigen Receptor Variable Region Exon Assembly
批准号:
10522226
负责人:
Frederick W. Alt
金额:
$71.7万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
未结题
起止时间:
1983-04-01 至 2027-05-31
关键词:
AddressAntibody RepertoireAntigen ReceptorsArchitectureAreaB-LymphocytesBiological AssayCellsChromatinChromatin LoopChromosomesComplexDataDevelopmentDiffusionDistalElementsEndonuclease VEventExonsFundingG1 ArrestGeneration of Antibody DiversityGenesGenetic RecombinationGenetic TranscriptionGoalsHumanIGH@ gene clusterIgKImmunologyIntercistronic RegionLightLymphocyteMalignant NeoplasmsMapsMediatingModificationMusPatternPlayPopulationProcessProteinsPublishingReactionResolutionRoleScanningT-LymphocyteTechnologyTestingTherapeutic antibodiesTrans-ActivatorsWorkabl Oncogenebasecell population studycohesinexperimental studygenome-widehigh throughput analysisin vivoinsightinterstitialnew technologyprogenitorprotein complextranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
7. Project Summary/Abstract.
During the past funding period, we discovered that the cohesin-mediated loop extrusion process
involved in genome-wide modulation of chromosome architecture plays fundamental roles in V(D)J
recombination and the generation of antibody diversity. In developing progenitor B cells, we found that
cohesin-mediated loop extrusion linearly presents Ig heavy chain locus (Igh) VH, D, and JH gene segments to
the RAG endonuclease for V(D)J recombination. Our preliminary data indicate that long-range V(D)J
recombination in the Igk light chain locus may occur, at least in part, by a mechanistically distinct process from
that of Igh. We propose 2 specific aims to elucidate the potentially differential mechanisms of Igh versus Igk
long-range V(D)J recombination. A major hypothesis guiding Aim 1 and Aim2 studies is that Igh achieves long
range V(D)J recombination via linear RAG chromatin scanning that leads to predominantly deletional
recombination events. A major hypothesis to be tested for Aim 2 is that Igk is structurally-optimized to employ
a related loop extrusion-based mechanism that accommodates both robust deletional and inverted Vk-to-
Jk joining. These hypotheses are supported by a wealth of published and preliminary data derived in large part
from powerful new technologies that we developed during the current funding period. In particular we
developed LAM-HTGTS-V(D)J-Seq to assay V(D)J recombination with unprecedented sensitivity and LAM-3C-
HTGTS to map sequence interactions across chromatin domains at far higher resolution than prior assays. We
further developed G1-arrested, RAG inducible v-Abl transformed pro-B cell cell ("v-Abl cell") approaches to test
roles specific cis elements or trans-acting factors in long-range RAG chromatin-scanning through introduced
Igh or Igk locus modifications and/or targeted protein depletion. Aims 1 and 2 experiments together will
compare and contrast, in depth, the long-range mechanisms used by Igh and Igk to incorporate Vs into the
V(D)J recombination reaction. While most initial Aim 1 and 2 studies will employ v-Abl cells; all key results will
be confirmed/extended by studies of normal progenitor and precursor B cell populations These studies may
reveal new paradigms for understanding V(D)J recombination in vivo and illuminate the range of mechanisms
employed for long-range V(D)J recombination in antigen receptor loci. Addressing Aim 1 and 2 goals should
greatly impact the immunology field by providing major new insights into fundamental mechanisms that
establish highly diverse primary antibody repertoires. The studies proposed in Aim 1 and 2 will also further
elucidate how impediments in the scanning path focus cryptic RSS targets within impeded areas of chromatin
for incorporation into the RAG complex and subsequent rearrangement. Thus, these studies should provide
critical information for understanding how RAG targets cryptic RSSs in other genes and promotes common
translocations or interstitial deletions frequently found in B and T lymphocyte cancers of developing
lymphocytes in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of DNA Double Strand Break Response in Suppression of Thymic Lymphoma
-
批准号:7780950
-
项目类别:
-
资助金额:$44.71万
-
财政年份:2010
-
负责人:Frederick W. Alt
-
依托单位:
Mouse models of severe combined immunodeficiencies
-
批准号:7614101
-
项目类别:
-
资助金额:$47.73万
-
财政年份:2009
-
负责人:Frederick W. Alt
-
依托单位:
Mechanisms that Regulate Antibody Class Switch Recombination and Somatic Hypermutation
-
批准号:10392890
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
Molecular Mechanisms of Class Switch Recombination
-
批准号:8386894
-
项目类别:
-
资助金额:$40.08万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
Molecular Mechanisms of Class Switch Recombination
-
批准号:7743798
-
项目类别:
-
资助金额:$42.36万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
AID Targeting Mechanisms for IgH Switch Recombination and Somatic Hypermutation
-
批准号:9228317
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
Mechanisms that Regulate Antibody Class Switch Recombination and Somatic Hypermutation
-
批准号:10612752
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
Molecular Mechanisms of Class Switch Recombination
-
批准号:7577240
-
项目类别:
-
资助金额:$42.33万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
Molecular Mechanisms of Class Switch Recombination
-
批准号:8197214
-
项目类别:
-
资助金额:$42.63万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
AID Targeting Mechanisms for IgH Switch Recombination and Somatic Hypermutation
-
批准号:8697880
-
项目类别:
-
资助金额:$43.85万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
Molecular Mechanisms of Class Switch Recombination
-
批准号:7995253
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
Molecular Mechanism of Translocations in B-Cell Lymphoma
-
批准号:7156133
-
项目类别:
-
资助金额:$40.2万
-
财政年份:2006
-
负责人:Frederick W. Alt
-
依托单位:
Role of H2AX and ATM in Suppression of Thymic Lymphomas
-
批准号:6989691
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2004
-
负责人:Frederick W. Alt
-
依托单位:
T Cell Development
-
批准号:6742737
-
项目类别:
-
资助金额:$0.87万
-
财政年份:2004
-
负责人:Frederick W. Alt
-
依托单位:
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
-
批准号:8220847
-
项目类别:
-
资助金额:$50.14万
-
财政年份:2003
-
负责人:Frederick W. Alt
-
依托单位:
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
-
批准号:8444354
-
项目类别:
-
资助金额:$45.76万
-
财政年份:2003
-
负责人:Frederick W. Alt
-
依托单位:
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
-
批准号:8029601
-
项目类别:
-
资助金额:$49.01万
-
财政年份:2003
-
负责人:Frederick W. Alt
-
依托单位:
ROLE OF VAV AND ITS EFFECTORS IN LYMPHOCYTE ACTIVATION
-
批准号:6496054
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2001
-
负责人:Frederick W. Alt
-
依托单位:
ROLE OF VAV AND ITS EFFECTORS IN LYMPHOCYTE ACTIVATION
-
批准号:6346235
-
项目类别:
-
资助金额:$42.66万
-
财政年份:2000
-
负责人:Frederick W. Alt
-
依托单位:
MURINE MODELS OF SEVERE COMBINED IMMUNODEFICIENCIES
-
批准号:6332448
-
项目类别:
-
资助金额:$27.63万
-
财政年份:2000
-
负责人:Frederick W. Alt
-
依托单位:
海外基金